Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus

Pediatric Diabetes

Volumn 6, Issue 4, 2005, Pages 206-212

  Del Roio Liberatore Jr , Raphael ^a   Barbosa, Sonia F C ^b   Alkimin, Maria das Graças ^b   Bellinati Pires, Raquel ^b   Florido, Marlene P C ^b   Isaac, Lourdes ^b   Kirschfink, Michael ^c   Grumach, Anete Sevciovic ^b  

^a Medical School   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

C4 isotypes; Complement; Immunoglobulin; Infection; Phagocyte; Type 1 diabetes mellitus

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C4B; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INSULIN;

ADOLESCENT; ARTICLE; BACTERICIDAL ACTIVITY; CANDIDA ALBICANS; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DISEASE PREDISPOSITION; DRUG DOSE REGIMEN; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNGICIDAL ACTIVITY; HEMOLYSIS; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION; INFECTION RISK; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NUTRITIONAL STATUS; PHAGOCYTOSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TURBIDIMETRY;

ADOLESCENT; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; COMPLEMENT C3; COMPLEMENT C4; DIABETES MELLITUS, TYPE 1; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; IMMUNOGLOBULINS; INFECTION; MALE; PHAGOCYTOSIS;

EID: 29544436669     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-543X.2005.00136.x     Document Type: Article

References (45)

1. Sperling MA, ed. Diabetes mellitus. In: Pediatric Endocrinology. Philadelphia: W.B. Saunders, 1996: 230-263.
2. Malerbi DA, Franco LJ. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. Diabetes Care 1992: 15: 1509-1516.
3. American Diabetes Association. Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 2004: 27: S15-S35.
4. Bisi H, Ruggeri GB, Longatro-Filho VS, Fernandes RY, De-Camargo NP, Cravero NP. Study in necropsy material of cause specific mortality in diabetics, in São Paulo, Brazil. Rev Paul Med 1993: 111: 229-304.
5. Gurevich I, Tafuro P. The compromised host. Cancer Nurs 1986: 9: 263-275.
6. Zargar AH, Wani AI, Masoodi SR, Laway BA, Bashir MI. A mortalidade no diabetes mellitus- dados coletados de uma região em desenvolvimento do globo. Diabetes Clinica 1999: 1: 4-10.
7. Miller ME, Baker I. Leukocyte functions in juvenile diabetes mellitus: humoral and cellular aspects. J Pediatr 1972: 81: 979-982.
8. Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabetes Metab 1992: 18: 187-201.
9. Mcmahon MM, Bistrian BR. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin N Am 1995: 9: 1-9.
10. Leibovici L, Yehezkelli Y, Porter A, Regev A, Krauze I, Harell D. Influence of diabetes and glycaemic control on the characteristics and outcome of common infections. Diabet Med 1996: 13: 457-463.
11. Edwards JE, Tillman DB, Miller ME, Pitchon HE. Infection and diabetes mellitus. West J Med 1979: 130: 515-521.
12. Kottra CJ. Infection in the compromised host - an overview. Heart Lung 1983: 12: 10-14.
13. Pozzilli P, Leslie RDG. Infection and diabetes: mechanisms and prospects for prevention. Diabet Med 1994: 11: 935-941.
14. Thonsen RW, Hundborg HH, Levang HH, Johnsen SP, Sorensen HT, Sschoender HC. Diabetes and outcome of community-acquired pneumococcal bacteremia. Diabetes Care 2004: 27: 70-76.
15. Liberatore Jr RDR. Contribution to the study of ketoacidosis diabetes in childhood. Thesis presented to Faculty of Medicine, University of São Paulo, São Paulo, 1995.
16. Check IJ, Piper M. Quantification of immunoglobulins. In: Rose NR, Friedman H, Fahey JL, eds. Manual of Clinical Laboratory Immunology, Washington, Am Soc Microbiol, 3rd edn, 1986: 138-151.
17. Lachmann PJ, Hobart MJ. Complement technology. In: Weir DM, ed. Handbook of Experimental Immunology, 3rd edn. Boston: Blackwell Scientific Publications, 1978: 15-23.
18. Chrispeels J, Bank S, Rittner C, Bitter-Suermann D. Sandwich enzyme linked immunosorbent assays for the quantification of the C4 isotypes (C4A and C4B) in human plasma. J Immunol Methods 1989: 125: 5-12.
19. Fujimura MD. Niveis sericos de imunoglobulinas em crianças normais e com síndrome nefrótica. São Paulo: Faculty of Medicine, University of São Paulo, 1990.
20. Ferriani VP, Barbosa JE, De Carvalho IF. Complement haemolytic activity (classical and alternative pathways), C3, C4 and factor B titres in healthy children. Acta Paediatr 1999: 88: 1062-1066.
21. Bellinati-Pires R, Melki SE, Dal Colletto GMD, Carneiro-Sampaio MMS. Evaluation of fluorochrome assay for assessing the bactericidal activity of neutrophils in human phagocyte dysfunctions. J Immunol Methods 1989: 119: 189-196.
22. Hostetter MK. Effects of hyperglycemia on C3 and Candida albicans. Diabetes 1990: 38: 271-275.
23. Noritake M, Katsura Y, Shinomiya N, Kanatani Y, Nagata N, Tsuru S. Intracellular hydrogen peroxide production by peripheral phagocytes from diabetic patients. Dissociation between polymorphonuclear leucocytes and monocytes. Clin Exp Immunol 1992: 88: 269-274.
24. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999: 341: 1906-1912.
25. Lawton AR, Cooper MD. Ontogeny of immunity. In: Stiehm ER, ed. Immunologic Disorders in Infants and Children, 4th edn. Philadelphia: W.B. Saunders Company, 1996: 1-13.
26. Sorensen Ru, Moore C. Immunology in the pediatrician's office. Ped Clin N Am 1994: 41: 691-714.
27. Salardi S, Zucchini S, Santoni R et al. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA (lc) in pediatric type 1 diabetic patients. Diabetes Care 2002: 25: 1840-1844.
28. Allen DB, Macdonald MJ. Artifacts in glycosylated hemoglobin values in pediatric patients. J Pediatr 1986: 109: 655-657.
29. Drash AL. The child, the adolescent and the diabetes control and complications trial. Diabetes Care 1993: 16: 1513-1517.
30. DCCT - The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus. J Pediatr 1994: 125: 177-188.
31. Cortona L, Avanzini MA, Martinelli M, Lorini R. Transient IgG subclass deficits in newly diagnosed diabetic children. Eur J Pediatr 1992: 151: 179-182.
32. Liblau RS, Caillat-Zucman S, Fischer AM, Bach JF, Boitard C. The prevalence of selective IgA deficiency in type 1 diabetes mellitus. APMIS 1992: 100: 709-712.
33. Cerutti F, Urbino A, Sacchetti C, Palomba E, Zoppo M, Tovo PA. Selective IgA deficiency in juvenile-onset insulin dependent diabetes mellitus. Pediatr Med Chir 1988: 10: 197-201.
34. Ardawi MSM, Nasrat HAN, Bahnassy AA. Serum immunoglobulin concentrations in diabetic patients. Diabet Med 1994: 11: 384-387.
35. Hoddinott S, Dornan J, Bear JC, Farid NR. Immunoglobulin levels, immunodeficiency and HLA in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1982: 23: 320-329.
36. Vergani D, Johnston C, B-Abdullah N, Barnett AH. Low serum C4 concentrations: an inhered predisposition to insulin dependent diabetes? Braz Med J 1983: 286: 926-928.
37. Charlesworth JA, Timmermans V, Golding J et al. The complement system in type 1 diabetes. Diabetologia 1987: 30: 372-379.
38. Anil S, Remani P, Vijayakumar T, Hari S. Cell-mediated and humoral immune responses in diabetic patients with periodontitis. Oral Surg Oral Med Oral Pathol 1990: 70: 44-48.
39. Fontana G, Lapolla A, Sanzari M et al. An Immunological evaluation of type II diabetic patients with periodontal disease. J Diabetes Complications 1999: 13: 23-30.
40. Bagdade JD, Stewart M, Walters E. Impaired granulocyte adherence - a reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 1978: 27: 677-681.
41. Del Muro EL, Herrera-Esperza R, Camacho G. Phagocytic function in diabetes mellitus. Arch Invest Méd (Méx) 1981: 13: 89-91.
42. Stevens DL, Bryant AE, Huffman J, Thompson K, Allen RC. Analysis of circulating phagocyte activity measured by whole blood luminescence: correlations with clinical status. J Infect Dis 1994: 170: 1463-1472.
43. Wilson RM, Reeves WG. Neutrophil phagocytosis and killing in insulin-dependent diabetes. Clin Exp Immunol 1986: 63: 478-484.
44. Delamaire M, Maugendre D, Moreno M, Goff MC, Allannic H, Genetet B. Exploration des différentes étapes du fonctionnement des polynucléaires neutrophiles chez les patients diabétiques. J Mal Vasc 1995: 20: 107-112.
45. Densen P. Complement Deficiencies and Infection. The Human Complement System in Health and Disease. New York: Marcel Dekker, 1998: 409-421.